About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.50 (+1.01%)
LTP ASX LTR Pharma Ltd
Carregando status da lista de acompanhamento…
LTR Pharma Ltd share price
LTP price activity
Último preço
$ 0,500
Variação (24h)
0,01 AUD (1,01%)
Volume
719.25K
Volume (média 4 sem.)
-
Abertura
$ 0,50
Variação do dia
$ 0,50 - $ 0,56
Fechamento anterior
$ 0,50
Último negócio
06 Oct, 5:10 am GMT+0
Atrasado
06 Oct, 5:10 am GMT+0
LTP price performance
4,17%
5D
-6,54%
1M
-30,56%
YTD
-25,37%
1Y
Atrasado
06 Oct, 5:10 am GMT+0
quote.marketSignals